By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc. (PANC)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 3 Sept 2025, 00:00
$5.36K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

PANC Stock Price Chart

Explore Panacos Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze PANC price movements and trends.

PANC Company Profile

Discover essential business fundamentals and corporate details for Panacos Pharmaceuticals, Inc. (PANC) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

14 Mar 2005

Employees

41.00

Website

CEO

John R. Barr

Description

Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.

PANC Financial Timeline

Browse a chronological timeline of Panacos Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

PANC Stock Performance

Access detailed PANC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run